【Dayeh Biomedical】Report on the Completion of Share Buyback Period
Dayeh Biomedical executed a share buyback from March 31 to May 25, 115. Out of the planned 7.5 million shares, 4.46 million were repurchased at an average price of 18.48 TWD, totaling 82.41 million TWD. The shortfall was due to a phased buyback strategy to maintain market stability.
📋 Article Processing Timeline
- 📰 Published: May 25, 2026 at 09:00
- 🔍 Collected: May 26, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 31, 2026 at 20:07 (132h 7m after Collected)
1. Original max buyback amount: 4,474,756,140 TWD. 2. Original period: 115/03/26~115/05/25. 3. Original target quantity: 7,500,000 shares. 4. Price range: 12.75~33.80 TWD. 5. Actual period: 115/03/31~115/05/25. 6. Actual quantity repurchased: 4,460,000 shares. 7. Total amount spent: 82,408,946 TWD. 8. Average price per share: 18.48 TWD. 9. Cumulative shares held: 4,460,000 shares. 10. Percentage of total issued shares: 0.55%. 11. Reason for incomplete execution: To balance market mechanisms and shareholder interests, the company adopted a phased buyback strategy based on stock price and volume. 12. Other: None.
FAQ
What is the result of Dayeh Biomedical's buyback?
They repurchased 4.46 million shares for approximately 82.41 million TWD.